TY - JOUR
T1 - New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases
AU - Bajaj, Jasmohan S
AU - Barbara, Giovanni
AU - DuPont, Herbert L
AU - Mearin, F
AU - Gasbarrini, Antonio
AU - Tack, Jan
PY - 2018
Y1 - 2018
N2 - N/A
AB - N/A
KW - Anti-Bacterial Agents
KW - Antibiotics
KW - Diverticular Diseases
KW - Gastrointestinal Microbiome
KW - Gut microenvironment
KW - Hepatic Encephalopathy
KW - Humans
KW - Irritable Bowel Syndrome
KW - Probiotics
KW - Randomized Controlled Trials as Topic
KW - Rifamycins
KW - Rifaximin
KW - Therapeutic treatments
KW - Anti-Bacterial Agents
KW - Antibiotics
KW - Diverticular Diseases
KW - Gastrointestinal Microbiome
KW - Gut microenvironment
KW - Hepatic Encephalopathy
KW - Humans
KW - Irritable Bowel Syndrome
KW - Probiotics
KW - Randomized Controlled Trials as Topic
KW - Rifamycins
KW - Rifaximin
KW - Therapeutic treatments
UR - https://publicatt.unicatt.it/handle/10807/136428
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85047405045&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85047405045&origin=inward
U2 - 10.1016/j.dld.2018.04.020
DO - 10.1016/j.dld.2018.04.020
M3 - Article
SN - 1590-8658
VL - 50
SP - 741
EP - 749
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
IS - 8
ER -